Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-16 Sale | 2024-12-18 9:00 pm | Replimune Group Inc. | REPL | Patel Sushil Chief Executive Officer | 10,000 | $12.42 | $124,200 | 202,014 (Direct) | View |
| 2024-11-18 Sale | 2024-11-20 9:31 pm | Replimune Group Inc. | REPL | Xynos Konstantinos Chief Medical Officer | 7,246 | $10.78 | $78,112 | 109,885 (Direct) | View |
| 2024-11-18 Sale | 2024-11-20 9:30 pm | Replimune Group Inc. | REPL | Sarchi Christopher Chief Commercial Officer | 5,207 | $10.78 | $56,131 | 87,045 (Direct) | View |
| 2024-08-16 Sale | 2024-08-19 8:00 pm | Replimune Group Inc. | REPL | Hill Emily Luisa Chief Financial Officer | 8,938 | $10.18 | $90,989 | 101,057 (Direct) | View |
| 2024-06-07 Sale | 2024-06-10 8:30 pm | Replimune Group Inc. | REPL | Xynos Konstantinos Chief Medical Officer | 15,881 | $7.5 | $119,108 | 117,131 (Direct) | View |
| 2024-05-16 Sale | 2024-05-20 8:06 pm | Replimune Group Inc. | REPL | Sarchi Christopher Chief Commercial Officer | 2,218 | $6.47 | $14,350 | 92,252 (Direct) | View |
| 2024-05-16 Sale | 2024-05-20 8:06 pm | Replimune Group Inc. | REPL | Schwendenman Andrew Chief Accounting Officer | 2,298 | $6.47 | $14,868 | 38,238 (Direct) | View |
| 2024-05-16 Sale | 2024-05-20 8:05 pm | Replimune Group Inc. | REPL | Love Colin Chief Operating Officer | 17,615 | $6.47 | $113,969 | 777,345 (Direct) | View |
| 2024-05-16 Sale | 2024-05-20 8:04 pm | Replimune Group Inc. | REPL | Astley-Sparke Philip Executive Chairman | 37,928 | $6.47 | $245,394 | 1,487,350 (Direct) | View |
| 2024-05-16 Sale | 2024-05-20 8:02 pm | Replimune Group Inc. | REPL | Coffin Robert Director | 11,464 | $6.47 | $74,172 | 1,821,872 (Direct) | View |
| 2024-05-16 Sale | 2024-05-20 8:01 pm | Replimune Group Inc. | REPL | Patel Sushil Chief Executive Officer | 20,194 | $6.47 | $130,655 | 212,014 (Direct) | View |
| 2024-05-16 Sale | 2024-05-20 8:00 pm | Replimune Group Inc. | REPL | Xynos Konstantinos Chief Medical Officer | 6,367 | $6.47 | $41,194 | 133,012 (Direct) | View |
| 2023-11-16 Sale | 2023-11-17 8:01 pm | Replimune Group Inc. | REPL | Xynos Konstantinos Chief Medical Officer | 7,313 | $10.92 | $79,858 | 112,714 (Direct) | View |
| 2023-11-16 Sale | 2023-11-17 8:00 pm | Replimune Group Inc. | REPL | Sarchi Christopher Chief Commercial Officer | 5,255 | $10.92 | $57,385 | 72,245 (Direct) | View |
| 2023-09-11 Sale | 2023-09-13 9:02 pm | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 5,658 | $20.01 | $113,214 | 435,802 (Direct) | View |
| 2023-08-22 Sale | 2023-08-24 8:30 pm | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 18,600 | $20.01 | $372,186 | 390,877 (Direct) | View |
| 2023-08-11 Sale | 2023-08-15 8:30 pm | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 1,400 | $20 | $28,000 | 368,727 (Direct) | View |
| 2023-07-10 Sale | 2023-07-11 9:00 pm | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 20,000 | $21.58 | $431,541 | 410,877 (Direct) | View |
| 2023-06-13 Sale | 2023-06-15 9:01 pm | Replimune Group Inc. | REPL | Lewis Tanya Chief Dev. Op. Officer | 12,860 | $24.06 | $309,395 | 135,293 (Direct) | View |
| 2023-06-13 Sale | 2023-06-15 9:00 pm | Replimune Group Inc. | REPL | Patel Sushil Chief Strategy Officer | 5,698 | $24.04 | $137,008 | 148,873 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-04 Option Award | 2024-09-05 8:10 pm | N/A 2034-09-04 | Replimune Group Inc. | REPL | Balachandran Madhavan Director | 64,000 | $0 | 64,000 (Direct) | View |
| 2024-08-30 Gift | 2024-08-30 8:00 pm | N/A N/A | Replimune Group Inc. | REPL | Astley-Sparke Philip Executive Chairman | 50,000 | $0 | 1,437,350 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:04 pm | N/A 2034-04-01 | Replimune Group Inc. | REPL | Peeples-Dyer Veleka Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:03 pm | N/A 2034-04-01 | Replimune Group Inc. | REPL | Patel Sushil Chief Executive Officer | 333,335 | $0 | 482,208 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:02 pm | N/A 2034-04-01 | Replimune Group Inc. | REPL | Pucci Paolo Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:02 pm | N/A 2034-04-01 | Replimune Group Inc. | REPL | Xynos Konstantinos Chief Medical Officer | 106,665 | $0 | 219,379 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:01 pm | N/A 2034-04-01 | Replimune Group Inc. | REPL | Dhingra Kapil Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:01 pm | N/A 2034-04-01 | Replimune Group Inc. | REPL | Hill Emily Luisa Chief Financial Officer | 106,665 | $0 | 189,995 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:01 pm | N/A 2034-04-01 | Replimune Group Inc. | REPL | Sarchi Christopher Chief Commercial Officer | 88,900 | $0 | 161,145 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:01 pm | N/A 2034-04-01 | Replimune Group Inc. | REPL | SLATTERY JOSEPH P Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:00 pm | N/A 2034-04-01 | Replimune Group Inc. | REPL | Weinand Dieter Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:00 pm | N/A 2034-04-01 | Replimune Group Inc. | REPL | Oliger Christy J. Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:00 pm | N/A 2034-04-01 | Replimune Group Inc. | REPL | Levitsky Hyam Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:00 pm | N/A 2034-04-01 | Replimune Group Inc. | REPL | Schwendenman Andrew Chief Accounting Officer | 71,100 | $0 | 93,861 (Direct) | View |
| 2023-09-18 Option Award | 2023-09-20 8:04 pm | N/A 2033-09-18 | Replimune Group Inc. | REPL | Hill Emily Luisa Chief Financial Officer | 208,330 | $0 | 208,330 (Direct) | View |
| 2023-09-11 Exercise | 2023-09-13 9:02 pm | N/A 2027-07-26 | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 5,658 | $0 | 435,802 (Direct) | View |
| 2023-09-11 Exercise | 2023-09-13 9:02 pm | N/A N/A | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 5,658 | $3.3 | 435,802 (Direct) | View |
| 2023-08-22 Exercise | 2023-08-24 8:30 pm | N/A 2027-07-26 | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 18,600 | $0 | 390,877 (Direct) | View |
| 2023-08-22 Exercise | 2023-08-24 8:30 pm | N/A N/A | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 13,600 | $3.3 | 390,877 (Direct) | View |
| 2023-08-22 Exercise | 2023-08-24 8:30 pm | N/A N/A | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 5,000 | $15.5 | 390,877 (Direct) | View |
| 2023-08-11 Exercise | 2023-08-15 8:30 pm | N/A 2027-07-26 | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 1,400 | $0 | 368,727 (Direct) | View |
| 2023-08-11 Exercise | 2023-08-15 8:30 pm | N/A N/A | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 1,400 | $3.3 | 368,727 (Direct) | View |
Ownership | 2023-07-26 8:00 pm | N/A N/A | Replimune Group Inc. | REPL | Sarchi Christopher Chief Commercial Officer | 0 | $0 | 193,750 (Direct) | View |
| 2023-07-10 Exercise | 2023-07-11 9:00 pm | N/A 2027-07-26 | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 20,000 | $0 | 410,877 (Direct) | View |
| 2023-07-10 Exercise | 2023-07-11 9:00 pm | N/A N/A | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 15,000 | $3.3 | 410,877 (Direct) | View |
| 2023-07-10 Exercise | 2023-07-11 9:00 pm | N/A N/A | Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer | 5,000 | $15.5 | 410,877 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 08:13 am | N/A 2033-06-01 | Replimune Group Inc. | REPL | Peeples-Dyer Veleka Director | 50,400 | $0 | 50,400 (Direct) | View |